Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 4th Ophthalmic Drug Delivery Summit. 

Melissa Calton, Vice President - Early, Stage Product Development, 4D Molecular Therapeutics

Melissa Calton

Vice President - Early, Stage Product Development
4D Molecular Therapeutics
Amy Hopkin Director, Search and Evaluation - Eye Care AbbVie

Amy Hopkin

Director, Search and Evaluation - Eye Care
AbbVie
Allison Hoch, Director, AbbVie

Allison Hoch

Director
AbbVie
Romu Corbau, Chief Scientific Officer, Adverum

Romu Corbau

Chief Scientific Officer
Adverum
Lena Marie Spindler, Scientist Formulation Development, Boehringer Ingelheim

Lena Marie Spindler

Scientist Formulation Development
Boehringer Ingelheim
Rami Skaliter, Chief Executive Officer, Cell Cure Neurosciences

Rami Skaliter

Chief Executive Officer
Cell Cure Neurosciences
Victor Chong, Chief Medical Officer, Executive Vice President, Clearside Biomedical

Victor Chong

Chief Medical Officer, Executive Vice President
Clearside Biomedical
Aaron Weinroth, Chief Operating Officer, Dragonfleye Therapeutics

Aaron Weinroth

Chief Operating Officer
Dragonfleye Therapeutics
Keren Mano Tamir, Scientific Strategy Communications & Business Development Head, Everads Therapy

Keren Mano Tamir

Scientific Strategy Communications & Business Development Head
Everads Therapy
Justin Creel, Executive Director - Device Development, Genentech

Justin Creel

Executive Director - Device Development
Genentech
Saidur Rahaman, Senior Principal Engineer, Johnson & Johnson

Saidur Rahaman

Senior Principal Engineer
Johnson & Johnson
Kevin Pritchard, CSO, NnOptima Limited

Kevin Pritchard

CSO
NnOptima Limited
Arun Upadhyay, Chief Scientific Officer, Head of R&D Ocugen

Arun Upadhyay

Chief Scientific Officer, Head of R&D
Ocugen
Chris Romeo, Principal Scientist, Device and Formulation, Perfuse Therapeutics

Chris Romeo

Principal Scientist, Device and Formulation
Perfuse Therapeutics
Michael O’Rourke, Chief Executive Officer, Re-Vana Therapeutics

Michael O’Rourke

Chief Executive Officer
Re-Vana Therapeutics
Raghu Raj, Head of Radar Imaging & Target Identification Section, Re-Vana Therapeutics

Raghu Raj

Head of Radar Imaging & Target Identification Section
Re-Vana Therapeutics
Peter Petrochenko, Associate Director, Regeneron

Peter Petrochenko

Associate Director
Regeneron
Wendy Naimark, Chief Technology Officer, Ripple Therapeutics

Wendy Naimark

Chief Technology Officer
Ripple Therapeutics
Kirsi Rilla, Research director, University of East Finland

Kirsi Rilla

Research director
University of East Finland
Arto Urtti, Professor, University of Eastern Finland

Arto Urtti

Professor
University of Eastern Finland
Wesley Jackson, President & Chief Scientific Officer, Valitor

Wesley Jackson

President & Chief Scientific Officer
Valitor
Screenshot-2025-08-12-093824-768x506
Explore the Agenda

Discover the latest innovations transforming ocular drug delivery, from long-acting implants to suprachoroidal access. 

View Presentations & Speakers
Screenshot-2025-08-12-093745-768x501
Partner With Us

Connect with top-tier drug developers actively seeking expert collaborators across formulation, devices, imaging, and more. 

Explore Sponsorship Options
Screenshot-2025-08-12-093857-768x507
Join Other Ocular Delivery Experts

Register now and look forward to networking with 80+ leading scientists and innovators advancing the future of ophthalmic therapeutics. 

Register Now